273 related articles for article (PubMed ID: 34194284)
1. Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients.
Zhu K; Xia C; Chen J; Yu C; Gao T; Yan J; Shao N; Zhu P; Sun B; Ren X; Zhang Y
Mediators Inflamm; 2021; 2021():5576596. PubMed ID: 34194284
[TBL] [Abstract][Full Text] [Related]
2. Activated leukocyte cell adhesion molecule as a biomarker for disease severity and efficacy of sublingual immunotherapy in allergic rhinitis.
Xie S; Zhang H; Wang F; Liu Y; Gao K; Zhang J; Fan R; Xie S; Xie Z; Jiang W
Int Immunopharmacol; 2020 Nov; 88():106975. PubMed ID: 33182046
[TBL] [Abstract][Full Text] [Related]
3. Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis.
Xie S; Zhang H; Wang F; Xie Z; Jiang W; Gao K
Front Pharmacol; 2021; 12():681724. PubMed ID: 34305594
[No Abstract] [Full Text] [Related]
4. Serum Periostin as a Biomarker for Predicting Clinical Response to House Dust Mite Sublingual Immunotherapy in Allergic Rhinitis.
Hoshino M; Akitsu K; Kubota K; Ohtawa J
J Allergy Clin Immunol Pract; 2021 May; 9(5):1864-1870. PubMed ID: 33290915
[TBL] [Abstract][Full Text] [Related]
5. House dust mite sublingual immunotherapy in allergic rhinitis.
Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
7. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis.
Meng Q; Liu X; Li P; He L; Xie J; Gao X; Wu X; Su F; Liang Y
Int Forum Allergy Rhinol; 2016 Aug; 6(8):862-70. PubMed ID: 27012942
[TBL] [Abstract][Full Text] [Related]
8. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
Wang ZX; Shi H
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Efficacy of Dust Mite Sublingual Immunotherapy in Low-Response Allergic Rhinitis Patients after Dose Increment at 6 Months: A Prospective Study.
Gao Y; Lin X; Ma J; Wei X; Wang Q; Wang M
Int Arch Allergy Immunol; 2020; 181(4):311-319. PubMed ID: 32069460
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
[TBL] [Abstract][Full Text] [Related]
13. Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis.
Zhou Y; Xu M; Gong W; Kang X; Guo R; Wen J; Zhou D; Wang M; Shi D; Jing Q
Mediators Inflamm; 2022; 2022():3378035. PubMed ID: 35733520
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From Kashmir.
Baba SM; Rasool R; Gull A; Qureshi TA; Beigh AH; Qadri Q; Shah ZA
Front Immunol; 2021; 12():723814. PubMed ID: 34721385
[TBL] [Abstract][Full Text] [Related]
15. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis.
Meteran H; Backer V
Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839
[No Abstract] [Full Text] [Related]
16. Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis.
Zhou Y; Feng Z; Wen J; Yang C; Jing Q
J Inflamm Res; 2023; 16():4845-4855. PubMed ID: 37904786
[TBL] [Abstract][Full Text] [Related]
17. Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy.
Wang C; Wang K; Liu S; Qin X; Chen K; Zhang T
Int J Pediatr Otorhinolaryngol; 2016 Feb; 81():15-20. PubMed ID: 26810282
[TBL] [Abstract][Full Text] [Related]
18. Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy.
Ihara F; Sakurai D; Yonekura S; Iinuma T; Yagi R; Sakurai T; Ito T; Matsuura A; Morimoto Y; Arai T; Suzuki S; Katayama K; Nakayama T; Okamoto Y
Allergy; 2018 Sep; 73(9):1823-1832. PubMed ID: 29517806
[TBL] [Abstract][Full Text] [Related]
19. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
[TBL] [Abstract][Full Text] [Related]
20. Suppression of TIM-1 predicates clinical efficacy of sublingual immunotherapy for allergic rhinitis in children.
Lin Z; Zhou L; Luo X; Xia W; Chen D; Xu R; Wang J; Luo R; Xu G; Li H
Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1345-9. PubMed ID: 23800473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
